Genetic Technologies (GENE) seeking strategic alternatives
Genetic Technologies Limited (GENE), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for
Read More